Data / Drug companies / Inke SA
Inke SA: 26 products in the FDA NDC directory, labeler code 64567
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Inke SA (labeler code 64567) lists 26 products in the FDA National Drug Code Directory. By type: 26 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on October 14, 2025.
The request: Watch Inke SA (FDA labeler code 64567): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 64567
- Products in commercial distribution
- 26
- Packages
- 26
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- July 20, 2006
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 26 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 26 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 26 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ensifentrine | 64567-0033 | Powder | Bulk ingredients | October 14, 2025 |
| Tafamidis meglumine | 64567-0032 | Powder | Bulk ingredients | June 13, 2025 |
| Olodaterol hydrochloride | 64567-0031 | Powder | Bulk ingredients | July 17, 2023 |
| Umeclidinium bromide | 64567-0030 | Powder | Bulk ingredients | January 13, 2022 |
| Revefenacin trihydrate | 64567-0029 | Powder | Bulk ingredients | January 13, 2022 |
| Aclidinium bromide | 64567-0028 | Powder | Bulk ingredients | January 13, 2022 |
| Vilanterol trifenatate | 64567-0027 | Powder | Bulk ingredients | January 20, 2021 |
| Tiotropium bromide monohydrate | 64567-0026 | Powder | Bulk ingredients | January 20, 2021 |
| Tetrabenazine | 64567-0025 | Powder | Bulk ingredients | January 20, 2021 |
| Indacaterol maleate | 64567-0024 | Powder | Bulk ingredients | January 20, 2021 |
| Clevidipine butyrate | 64567-0023 | Powder | Bulk ingredients | January 20, 2021 |
| Arformoterol tartrate | 64567-0022 | Powder | Bulk ingredients | January 20, 2021 |
| Aprepitant | 64567-0021 | Powder | Bulk ingredients | January 14, 2021 |
| Arformoterol tartrate form d | 64567-0020 | Powder | Bulk ingredients | July 19, 2018 |
| Glycopyrrolate | 64567-0018 | Powder | Bulk ingredients | July 28, 2017 |
| Olanzapine | 64567-0017 | Powder | Bulk ingredients | January 24, 2013 |
| Fluconazole | 64567-0002 | Powder | Bulk ingredients | June 7, 2011 |
| Zolmitriptan | 64567-0016 | Powder | Bulk ingredients | October 28, 2009 |
| Rizatriptan benzoate | 64567-0013 | Powder | Bulk ingredients | October 28, 2009 |
| Granisetron hydrochloride | 64567-0009 | Powder | Bulk ingredients | October 28, 2009 |
| Granisetron base | 64567-0010 | Powder | Bulk ingredients | August 20, 2009 |
| Ondansetron base | 64567-0008 | Powder | Bulk ingredients | August 19, 2009 |
| Ondansetron hydrochloride | 64567-0005 | Powder | Bulk ingredients | August 19, 2009 |
| Formoterol fumarate dihydrate | 64567-0006 | Powder | Bulk ingredients | June 17, 2008 |
| Salmeterol xinafoate | 64567-0007 | Powder | Bulk ingredients | March 27, 2008 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.